Holen Sie sich die Stockscreener-App
1.54
0.65%
0.01
Handel nachbörslich:
1.55
0.01
+0.65%
Finanzdaten der Pyxis Oncology Inc-Aktie (PYXS)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
100.00%
-
|
2.82 | - | - | - |
Operating Expenses
|
3.95%
23.46
|
22.57 | 22.91 | 40.07 | 23.75 |
| Benefits Costs and Expenses |
5.32%
22.00
|
20.89 | 21.16 | 37.73 | 21.20 |
| Costs And Expenses |
5.32%
22.00
|
20.89 | 21.16 | 37.73 | 21.20 |
| Operating Income/Loss |
18.79%
-23.46
|
-19.75 | -22.91 | -40.07 | -23.75 |
| Nonoperating Income/Loss |
13.16%
1.458
|
1.679 | 1.756 | 2.334 | 2.551 |
| Income/Loss From Continuing Operations Before Tax |
21.76%
-22.00
|
-18.07 | -21.16 | -37.73 | -21.20 |
| Income Tax Expense/Benefit |
100.00%
-
|
0.283 | - | -2.164 | - |
| Income/Loss From Continuing Operations After Tax |
19.88%
-22.00
|
-18.35 | -21.16 | -35.57 | -21.20 |
|
Net Income/Loss
|
19.88%
-22.00
|
-18.35 | -21.16 | -35.57 | -21.20 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
1.03%
62.56
|
61.92 | 61.05 | 0.9338 | 60.72 |
| Diluted Average Shares |
1.03%
62.56
|
61.92 | 61.05 | 0.9338 | 60.72 |
| Basic Earnings Per Share |
16.67%
-0.35
|
-0.30 | -0.35 | -0.59 | -0.35 |
| Diluted Earnings Per Share |
16.67%
-0.35
|
-0.30 | -0.35 | -0.59 | -0.35 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.48%
1.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):